Mrinal M Gounder

20PUBLICATIONS
225CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)ChemotherapyPersonality and individual differences
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Apr 24, 2026
Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors.

|Feb 12, 2026
Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma.

Evan Rosenbaum, Fiona Ehrich, Mohammad Yosofvand

|Dec 01, 2025
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma.

Evan Rosenbaum, Rodrigo Gularte-Mérida, Evan Seffar

|Oct 20, 2025
Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi Trial.

Ravin Ratan, Bernd Kasper, Thierry Alcindor

|Aug 11, 2025
Milademetan in Advanced Solid Tumors with MDM2 Amplification and Wild-type TP53: Preclinical and Phase II Clinical Trial Results.

Ecaterina E Dumbrava, Thomas E Stinchcombe, Mrinal Gounder

|Jul 22, 2025
ctDNA as a Molecular Biomarker in the Phase II Trial of Imatinib plus Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumor.

Ciara M Kelly, Martina Bradic, Sara Saunds

Pageof 4

Frequent Collaborators

9 joint publications

Sandra P D'Angelo

9 joint publications

William D Tap

9 joint publications

Ping Chi

9 joint publications

Ciara M Kelly